Get startedLog in
    Picture of Tessera Defense and Homeland Security logo

    HLSQ — Tessera Defense and Homeland Security News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Biomx To Provide Latest Update On Positive Phase 1B/2A Clinical Trial Data For Bx004 At North American Cystic Fibrosis Conference

    Picture of Tessera Defense and Homeland Security logoTessera Defense and Homeland Security
    18/09/2024 14:03
    Sept 18 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX TO PROVIDE LATEST UPDATE ON POSITIVE PHASE 1B/2A
CLINICAL
TRIAL DATA FOR BX004 AT THE NORTH AMERICAN CYSTIC FIBROSIS
CONFERENCE
    * BIOMX INC - FDA GRANTS BX004 FAST TRACK AND ORPHAN DRUG
DESIGNATION
    * BIOMX INC - TO INITIATE PHASE 2B TRIAL IN CF PATIENTS WITH
P.
AERUGINOSA INFECTIONS

Source text for Eikon:  ID:nGNX7rkx5n 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Tessera Defense and Homeland Security

    See all news